{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:50:20Z","timestamp":1792839020494,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:00:00Z","timestamp":1583539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:00:00Z","timestamp":1583539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Governmental Funding of Clinical Research within National Health Services","award":["47737"],"award-info":[{"award-number":["47737"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ovarian cancer (OC) is usually detected in late clinical stages, and imaging at diagnosis is crucial. Peritoneal carcinomatosis (PC) and cardio phrenic lymph nodes (CPLN) are pathological findings of computed tomography (CT) and are relevant for surgical planning. Furthermore, mammographic breast density (BD) has shown an association with OC risk and might be prognostically relevant. However, it is not known if PC, CPLN, and BD are associated with aggressive OC subtypes and impaired OC survival. Herein, we investigated associations between three comprehensive image parameters and OC subtypes and survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Malm\u00f6 Diet and Cancer Study is a prospective study that included 17,035 women (1991\u20131996). Tumor information on 159 OC and information on OC specific survival (last follow-up, 2017-12-31) was registered. The CT and mammography closest to diagnosis were evaluated (Peritoneal Carcinomatosis Index PCI, CPLN, and BD). Associations between CT-PCI, CPLN, and BD vs. clinical stage [stage I vs. advanced stage (II-IV), histological type\/grade (high grade serous and endometrioid vs. other subtypes], and OC-specific survival were analyzed by logistic and Cox regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There was a significant association between higher CT-PCI score and advanced clinical stage (adjusted OR 1.26 (1.07\u20131.49)), adjusted for age at diagnosis and histological type\/grade. Increasing CT-PCI was significantly associated with impaired OC specific survival (adjusted HR 1.04 (1.01\u20131.07)), adjusted for age at diagnosis, histological type\/grade, and clinical stage. There was no significant association between PCI and histological type\/grade, nor between BD or CPLN vs. the studied outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Image PCI score was significantly associated with advanced clinical stages and impaired OC survival. An objective approach (based on imaging) to scoring peritoneal carcinomatosis in ovarian cancer could help surgeons and oncologists to optimize surgical planning, treatment, and care.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-020-00625-8","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T13:02:28Z","timestamp":1583586148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1116-5199","authenticated-orcid":false,"given":"Hanna","family":"Sartor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bjurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Asp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Br\u00e4ndstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"Kannisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Jirstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,7]]},"reference":[{"issue":"5","key":"625_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386.","journal-title":"Int J Cancer"},{"issue":"11","key":"625_CR2","first-page":"937","volume":"93","author":"CA Doubeni","year":"2016","unstructured":"Doubeni CA, Doubeni AR, Myers AE. Diagnosis and Management of Ovarian Cancer. Am Fam Physician. 2016;93(11):937\u201344.","journal-title":"Am Fam Physician"},{"issue":"2","key":"625_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2214\/AJR.09.3522","volume":"194","author":"VR Iyer","year":"2010","unstructured":"Iyer VR, Lee SI. MRI, CT, and PET\/CT for ovarian Cancer detection and adnexal lesion characterization. Am J Roentgenol. 2010;194(2):311\u201321.","journal-title":"Am J Roentgenol"},{"issue":"997","key":"625_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1259\/bjr\/87415692","volume":"84","author":"SH Chandrashekhara","year":"2011","unstructured":"Chandrashekhara SH, Thulkar S, Srivastava DN, Kumar L, Hariprasad R, Kumar S, et al. Pre-operative evaluation of peritoneal deposits using multidetector computed tomography in ovarian cancer. Br J Radiol. 2011;84(997):38\u201343.","journal-title":"Br J Radiol"},{"issue":"1","key":"625_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1477-7819-9-171","volume":"9","author":"CD Duhr","year":"2011","unstructured":"Duhr CD, Kenn W, Kickuth R, Kerscher AG, Germer C-T, Hahn D, et al. Optimizing of preoperative computed tomography for diagnosis in patients with peritoneal carcinomatosis. World J Surg Oncol. 2011;9(1):171.","journal-title":"World J Surg Oncol"},{"key":"625_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res"},{"issue":"8","key":"625_CR7","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1245\/s10434-014-4329-7","volume":"22","author":"K Gasimli","year":"2015","unstructured":"Gasimli K, Braicu EI, Richter R, Chekerov R, Sehouli J. Prognostic and predictive value of the peritoneal Cancer index in primary advanced epithelial ovarian Cancer patients after complete Cytoreductive surgery: study of tumor Bank ovarian Cancer. Ann Surg Oncol. 2015;22(8):2729\u201337.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"625_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12957-018-1339-0","volume":"16","author":"A Llueca","year":"2018","unstructured":"Llueca A, Serra A, Rivadulla I, Gomez L, Escrig J. Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index. World J Surg Oncol. 2018;16(1):37.","journal-title":"World J Surg Oncol"},{"issue":"11","key":"625_CR9","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1007\/s00261-016-0817-5","volume":"41","author":"D Diaz-Gil","year":"2016","unstructured":"Diaz-Gil D, Fintelmann FJ, Molaei S, Elmi A, Hedgire SS, Harisinghani MG. Prediction of 5-year survival in advanced-stage ovarian cancer patients based on computed tomography peritoneal carcinomatosis index. Abdom Radiol (NY). 2016;41(11):2196\u2013202.","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"625_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ygyno.2018.11.001","volume":"152","author":"S Prader","year":"2019","unstructured":"Prader S, Vollmar N, du Bois A, Heitz F, Schneider S, Ataseven B, et al. Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer. Gynecol Oncol. 2019;152(1):76\u201381.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"625_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ygyno.2017.09.001","volume":"147","author":"RA Cowan","year":"2017","unstructured":"Cowan RA, Tseng J, Murthy V, Srivastava R, Long Roche KC, Zivanovic O, et al. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer. Gynecol Oncol. 2017;147(2):262\u20136.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"625_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/bcr2942","volume":"13","author":"NF Boyd","year":"2011","unstructured":"Boyd NF, Martin LJ, Yaffe MJ, Minkin S. Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res. 2011;13(6):223.","journal-title":"Breast Cancer Res"},{"key":"625_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/1471-2407-14-229","volume":"14","author":"A Olsson","year":"2014","unstructured":"Olsson A, Sartor H, Borgquist S, Zackrisson S, Manjer J. Breast density and mode of detection in relation to breast cancer specific survival: a cohort study. BMC Cancer. 2014;14:229.","journal-title":"BMC Cancer"},{"issue":"1","key":"625_CR14","doi-asserted-by":"publisher","first-page":"djt341","DOI":"10.1093\/jnci\/djt341","volume":"106","author":"KJ Wernli","year":"2014","unstructured":"Wernli KJ, O\u2019Meara ES, Kerlikowske K, Miglioretti DL, Muller CY, Onega T, et al. Investigation of mammographic breast density as a risk factor for ovarian cancer. J Natl Cancer Inst. 2014;106(1):djt341\u2013djt.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"625_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/00008469-200112000-00003","volume":"10","author":"J Manjer","year":"2001","unstructured":"Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, Lindstrom M, et al. The Malmo diet and Cancer study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev. 2001;10(6):489\u201399.","journal-title":"Eur J Cancer Prev"},{"issue":"2","key":"625_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/14034948020300020401","volume":"30","author":"J Manjer","year":"2002","unstructured":"Manjer J, Elmstahl S, Janzon L, Berglund G. Invitation to a population-based cohort study: differences between subjects recruited using various strategies. Scand J Public Health. 2002;30(2):103\u201312.","journal-title":"Scand J Public Health"},{"issue":"1","key":"625_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2796.1993.tb00647.x","volume":"233","author":"G Berglund","year":"1993","unstructured":"Berglund G, Elmstahl S, Janzon L, Larsson SA. The Malmo diet and Cancer study. Design and feasibility. J Intern Med. 1993;233(1):45\u201351.","journal-title":"J Intern Med"},{"key":"625_CR18","volume-title":"ACR BI-RADS\u00ae atlas, breast imaging reporting and data system","author":"CJSE D\u2019Orsi","year":"2013","unstructured":"D\u2019Orsi CJSE, Mendelson EB, Morris EA, et al. ACR BI-RADS\u00ae atlas, breast imaging reporting and data system. Reston: American College of Radiology; 2013."},{"issue":"5","key":"625_CR19","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.canep.2011.01.003","volume":"35","author":"J Br\u00e4ndstedt","year":"2011","unstructured":"Br\u00e4ndstedt J, Nodin B, Manjer J, Jirstr\u00f6m K. Anthropometric factors and ovarian cancer risk in the Malm\u00f6 diet and Cancer study. Cancer Epidemiol. 2011;35(5):432\u20137.","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"625_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1148\/radiol.2232011081","volume":"223","author":"FV Coakley","year":"2002","unstructured":"Coakley FV, Choi PH, Gougoutas CA, Pothuri B, Venkatraman E, Chi D, et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology. 2002;223(2):495\u20139.","journal-title":"Radiology"},{"issue":"1","key":"625_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11547-016-0682-x","volume":"122","author":"A Laghi","year":"2017","unstructured":"Laghi A, Bellini D, Rengo M, Accarpio F, Caruso D, Biacchi D, et al. Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis. Radiol Med. 2017;122(1):1\u201315.","journal-title":"Radiol Med"},{"issue":"6","key":"625_CR22","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A du Bois","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux pour les etudes des cancers de l'Ovaire (GINECO). Cancer. 2009;115(6):1234\u201344.","journal-title":"Cancer"},{"issue":"5","key":"625_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1447-0756.2011.01569.x","volume":"37","author":"F Khoury-Collado","year":"2011","unstructured":"Khoury-Collado F, Chi DS. Recent surgical management of ovarian cancer. J Obstet Gynaecol Res. 2011;37(5):379\u201382.","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"625_CR24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1148\/radiol.2272011747","volume":"227","author":"G Brown","year":"2003","unstructured":"Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology. 2003;227(2):371\u20137.","journal-title":"Radiology"},{"issue":"2","key":"625_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.molonc.2009.02.001","volume":"3","author":"SJ Ramus","year":"2009","unstructured":"Ramus SJ, Gayther SA. The contribution of BRCA1 and BRCA2 to ovarian cancer. Mol Oncol. 2009;3(2):138\u201350.","journal-title":"Mol Oncol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00625-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-020-00625-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00625-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:14:28Z","timestamp":1615076068000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-020-00625-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["625"],"URL":"https:\/\/doi.org\/10.1186\/s13048-020-00625-8","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,7]]},"assertion":[{"value":"16 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Regional Ethics Committee in Lund, Sweden (committee\u2019s reference number: LU 51\u201390 and 530\/2008). Informed consent was obtained from individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}